References: Vulvovaginitis caused by Candida and related species in adults
Acs N, Banhidy F, Puho E, Czeizel AE. Teratogenic effects of vaginal boric acid treatment during pregnancy. Int J Gynaecol Obstet 2006;93(1):55-6. https://www.ncbi.nlm.nih.gov/pubmed/16530197
Denison HJ, Worswick J, Bond CM, Grimshaw JM, Mayhew A, Gnani Ramadoss S, et al. Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database Syst Rev 2020;8:CD002845. https://www.ncbi.nlm.nih.gov/pubmed/32845024
Hong E, Dixit S, Fidel PL, Bradford J, Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J Low Genit Tract Dis 2014;18(1):31-8. https://www.ncbi.nlm.nih.gov/pubmed/23760143
Keighley C, Cooley L, Morris AJ, Ritchie D, Clark JE, Boan P, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J 2021;51 Suppl 7:89-117. https://www.ncbi.nlm.nih.gov/pubmed/34937142
Liu D, Zhang C, Wu L, Zhang L, Zhang L. Fetal outcomes after maternal exposure to oral antifungal agents during pregnancy: A systematic review and meta-analysis. Int J Gynaecol Obstet 2020;148(1):6-13. https://www.ncbi.nlm.nih.gov/pubmed/31691277
Nguyen Y, Lee A, Fischer G. Management of chronic vulvovaginal candidiasis: a long term retrospective study. Australas J Dermatol 2017;58(4):e188-e92. https://www.ncbi.nlm.nih.gov/pubmed/27250078
Ong JJ, Bourne C, Dean JA, Ryder N, Cornelisse VJ, Murray
S, et al. Australian sexually transmitted infection (STI) management guidelines
for use in primary care 2022 update. Sex Health 2023;20(1):1-8.
https://www.ncbi.nlm.nih.gov/pubmed/36356948
Rosa MI, Silva BR, Pires PS, Silva FR, Silva NC, Silva FR, et al. Weekly fluconazole therapy for recurrent vulvovaginal candidiasis: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 2013;167(2):132-6. https://www.ncbi.nlm.nih.gov/pubmed/23280281
Saxon C, Edwards A, Rautemaa-Richardson R, Owen C, Nathan B, Palmer B, et al. British Association for Sexual Health and HIV national guideline for the management of vulvovaginal candidiasis (2019). Int J STD AIDS 2020;31(12):1124-44. https://pubmed.ncbi.nlm.nih.gov/32883171/
Sobel JD, Brooker D, Stein GE, Thomason JL, Wermeling DP, Bradley B, et al. Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol 1995;172(4 Pt 1):1263-8. https://www.ncbi.nlm.nih.gov/pubmed/7726267
Sobel JD, Kapernick PS, Zervos M, Reed BD, Hooton T, Soper D, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001;185(2):363-9. https://www.ncbi.nlm.nih.gov/pubmed/11518893
Sobel JD, Zervos M, Reed BD, Hooton T, Soper D, Nyirjesy
P, et al. Fluconazole susceptibility of vaginal isolates obtained from women
with complicated Candida vaginitis: clinical implications. Antimicrob Agents
Chemother 2003;47(1):34-8.
https://www.ncbi.nlm.nih.gov/pubmed/12499165
Zhang Z, Zhang X, Zhou YY, Jiang CM, Jiang HY. The safety of oral fluconazole during the first trimester of pregnancy: a systematic review and meta-analysis. BJOG 2019;126(13):1546-52. https://www.ncbi.nlm.nih.gov/pubmed/31446677